Leng, H., & Simon, K. (2019). Translational potential of a novel osteoclast inhibitor, eliglustat, in myeloma bone disease.
Chicagoスタイル(17版)引用形式Leng, H., , K. Simon. Translational Potential of a Novel Osteoclast Inhibitor, Eliglustat, in Myeloma Bone Disease. 2019.
MLA(9版)引用形式Leng, H., , K. Simon. Translational Potential of a Novel Osteoclast Inhibitor, Eliglustat, in Myeloma Bone Disease. 2019.
警告: この引用は必ずしも正確ではありません.